Greer moves to V Foundation; Gentry named chair at UF
Gentry to chair University of Florida BMB department
Matthew Gentry, until lately a professor of molecular and cellular biochemistry at the University of Kentucky College of Medicine, has been appointed chair of the biochemistry and molecular biology department at the University of Florida College of Medicine. He will start in late August.
Gentry studies glycogen metabolism and how it goes awry in cancer and neurodegenerative disorders. Much of his early work focused on Lafora disease, a rare genetic disorder that causes progressive epilepsy beginning in adolescence. Lafora disease begins with the accumulation of insoluble polysaccharides in neurons and astrocytes. In collaboration with multiple groups and companies, Gentry’s laboratory has developed several potential therapeutic approaches for Lafora disease. He has worked with patients and their families to organize scientific meetings sponsored by a patient advocacy group called Chelsea's Hope.
Gentry earned his Ph.D. at Syracuse University and was a postdoc at the University of California San Diego with Jack Dixon before joining the University of Kentucky faculty. He is a member of the American Society for Biochemistry and Molecular Biology Council, former chair of the ASBMB's public affairs advisory committee and a member of the Journal of Biological Chemistry editorial board.
Greer joins V Foundation
Susanna Greer, until recently a senior scientific director at the American Cancer Society, has assumed a new position as the chief scientific officer at the V Foundation for Cancer Research, a North Carolina–based nonprofit. She will work with the foundation's scientific advisory committee to set funding priorities.
Greer earned her Ph.D. in microbiology and immunology at the University of Alabama at Birmingham, and was a postdoc at the University of North Carolina Chapel Hill. She spent just over 10 years as a professor studying cancer epigenetics at Georgia State University, earning tenure before she started a scientific communication consultancy and transitioned into the nonprofit world.
Greer serves on the Council and the Finance Committee of American Society for Biochemistry and Molecular Biology and was named an ASBMB fellow earlier this year. She also has served on several National Cancer Institute committees and was previously chair of the ASBMB committee on outreach and science communication.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles
What seems dead may not be dead
Vincent Tagliabracci will receive the Earl and Thressa Stadtman Distinguished Scientist Award at the ASBMB Annual Meeting, April 12–15 in Chicago.
'You can't afford to be 15 years behind the parasite'
David Fidock will receive the Alice and C.C. Wang Award in Molecular Parasitology at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.
Elucidating how chemotherapy induces neurotoxicity
Andre Nussenzweig will receive the Bert and Natalie Vallee Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.
ASBMB committees welcome new members
Committee members serve terms of two to five years, and a number of new members have joined. We also thank those whose terms have ended.
Curiosity turned a dietitian into a lipid scientist
Judy Storch will receive the Avanti Award in Lipids at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.
From receptor research to cancer drug development: The impact of RTKs
Joseph Schlessinger will receive the ASBMB Herbert Tabor Research Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.